Cel-Sci Corporation (CVM) Social Stream
CEL SCI CORP (CVM) Price Targets From Analysts
Use the tables below to see what analysts covering CEL SCI CORP think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-24 | 1 | $13 | $13 | $13 | $2.46 | 428.46% |
| 2023-01-03 | 1 | $16 | $13 | $14.5 | $2.46 | 489.43% |
| 2023-03-09 | 1 | $13 | $10 | $11.5 | $2.46 | 367.48% |
| 2023-05-16 | 1 | $11 | $10 | $10.5 | $2.46 | 326.83% |
| 2023-12-08 | 1 | $10 | $7 | $8.5 | $2.46 | 245.53% |
Price Target Last Issued December 8, 2023
The Trend in the Analyst Price Target
Over the past 43 months, CVM's average price target has gone down $12.5.
Over the past 39 weeks, CVM's average upside potential has been 364.15%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-09 | 1 | 13 | 10 | 11.5 | 2.57 | 347.47% |
| 2023-05-16 | 1 | 11 | 10 | 10.5 | 2.64 | 297.73% |
| 2023-10-09 | 1 | 10 | 7 | 8.5 | 1.13 | 652.21% |
| 2023-11-08 | 1 | 10 | 7 | 8.5 | 2.55 | 233.33% |
| 2023-12-08 | 1 | 10 | 7 | 8.5 | 2.66 | 219.55% |
CVM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
CVM's average broker recommendation rating improved by 0 over the prior 41 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, CEL SCI CORP's number of analysts covering the stock is higher than just about none of of them.
- CVM has a higher upside potential (average analyst target price relative to current price) than 459.43% of all US stocks.
- CVM has a lower variance in analysts' estimates than 52.12% of Pharmaceutical Products stocks.
- In the context of Healthcare stocks, CEL SCI CORP's average analyst price target is higher than 101.68% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CEL SCI CORP are VXRT, CRBU, and FUSN.
View All Top Stocks by Price Target
Is CVM a Buy, Hold or Sell? See the POWR Ratings now!